Reports
Sale
Global Nanotechnology in Medical Devices Market Share, Size, Analysis, Forecast: By Product: Active Implantable Devices, Biochips, Implantable Materials, Medical Textiles, Wound Dressings, Others; By Applications: Therapeutic Applications, Others; By End User: By Distribution Channel; Regional Analysis; Supplier Landscape; 2023-2031
Global Nanotechnology in Medical Devices Market Outlook
The global nanotechnology in medical devices market size attained a value of USD 7.55 billion in 2022. The market is further expected to grow at a CAGR of 10.20% between 2023 and 2028, to reach a value of USD 13.31 billion by 2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Nanotechnology in medical devices refers to the usage of nanotechnology for medical device applications, increasing the flexibility and potential of technology in medical devices. Nanotechnology involves the manipulation of near-atomic scale matter to create new devices, materials, and structures. In medical devices, nanotechnology enhances the ability of the medical device, allowing them to precisely target a specific tissue or an organ.
- The increasing prevalence of oncological and musculoskeletal disorders is driving the nanotechnology in medical devices market growth. Factors such as growing geriatric population and prevalence of sedentary lifestyles among working populations are leading to an escalation in the cases of cancers and musculoskeletal conditions.
- Rising investments towards advancements in nanotechnology-based implants for orthopaedic applications are crucial trends in the market. In addition, the increasing penetration of internet of things (IoT) and artificial intelligence is further leading to the development of superior and highly efficient nanotech medical devices.
- The increasing healthcare expenditure across the emerging economies, advancements in 3D implants, and the growing efforts of various governments to improve diagnostic and treatment facilities across healthcare units are some of the major trends in the nanotechnology in medical devices market.
Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the market is segmented into active implantable devices, biochips, implantable materials, and medical textiles and wound dressings, among others. Active implantable devices are further divided based on type into cardiac rhythm management devices, retinal implants, and hearing aid devices. Biochips are further bifurcated based on type into DNA microarrays and lab-on-chip. Implantable materials are further segmented based on type into bone substitute materials and dental restorative materials.
On the basis of application, the market is classified into therapeutic applications, diagnostic applications, and research applications. The regional markets for nanotechnology in medical devices are divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global nanotechnology in medical devices market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Smith & Nephew plc
- Stryker Corporation
- Abbott Laboratories
- PerkinElmer Inc.
- Starkey Laboratories, Inc.
- Others
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Share by Product
The implantable material segment, based on product, accounts for a healthy share of the nanotechnology in medical devices market. The increasing use of nanotechnology to produce bone substitute materials in order to treat musculoskeletal diseases is driving the segment’s growth. In addition, nanomaterials are emerging as a promising therapeutic option for organ and tissue replacement procedures, as well as for bone regeneration. Hence, the increasing prevalence of musculoskeletal injuries among populations worldwide is fuelling the growth of this segment. Moreover, research and innovations in the field of tissue engineering are expected to generate a steady demand for implantable materials in the forecast period. The growing dental care infrastructure and increasing awareness regarding regular check-ups and dental care are also bolstering the demand for dental restorative materials.
Market Share by Application
Based on application, the diagnostic applications segment accounts for a significant share in the nanotechnology in medical devices market. This can be attributed to the importance of timely and accurate diagnoses in the treatment and prognoses of various chronic conditions. Emergence of medical devices based on nanotechnology are gaining traction across the healthcare units as these are highly advanced and reliable for the diagnosis of conditions such as osteoporosis and cancer. Over the forecast period, the anticipated increase in application of nanotechnology-based medical devices for early-stage diagnoses of various cancers for improved outcomes is expected to fuel the growth of the market for nanotechnology in medical devices.
Competitive Landscape
Smith & Nephew plc is a leading medical equipment manufacturing company that operates in more than 100 countries across the world. The company caters to the medical device demands of advanced wound management, orthopaedic trauma, and sports medicine, among others. It was established in the year 1856 and is headquartered in London, United Kingdom.
Stryker Corporation is a multinational medical technology corporation which provides medical and surgical equipment, orthopaedic therapeutics, neurotechnology for advanced treatment, and advanced training and education for budding doctors. The company was founded in the year 1941 and is currently headquartered in Michigan in the United States.
Abbott Laboratories is a leading multinational manufacturing company of medical devices and healthcare products which also provides expertise in nutritional products. The company has significant sales of its cardiovascular, neuromodulation diagnostic, and pharmaceutical products. It was established in 1888 and is headquartered in Illinois, United States.
Other market players include PerkinElmer Inc., and Starkey Laboratories, Inc., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nanotechnology in Medical Devices Market Overview
3.1 Global Nanotechnology in Medical Devices Market Historical Value (2016-2022)
3.2 Global Nanotechnology in Medical Devices Market Forecast Value (2023-2031)
4 Global Nanotechnology in Medical Devices Market Landscape
4.1 Global Nanotechnology in Medical Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nanotechnology in Medical Devices Product Landscape
4.2.1 Analysis by Type of Devices
4.2.2 Analysis by End User
4.2.3 Analysis by Distribution Channel
5 Global Nanotechnology in Medical Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nanotechnology in Medical Devices Market Segmentation
6.1 Global Nanotechnology in Medical Devices Market by Product
6.1.1 Market Overview
6.1.2 Active Implantable Devices
6.1.2.1 Cardiac Rhythm Management Devices
6.1.2.2 Hearing Aid Devices
6.1.2.3 Retinal Implants
6.1.3 Biochips
6.1.3.1 DNA Microarrays
6.1.3.2 Lab-On-Chip
6.1.4 Implantable Materials
6.1.4.1 Dental Restorative Materials
6.1.4.2 Bone Substitute Materials
6.1.5 Medical Textiles
6.1.6 Wound Dressings
6.1.7 Others
6.2 Global Nanotechnology in Medical Devices Market by Applications
6.2.1 Market Overview
6.2.2 Therapeutic Applications
6.2.3 Diagnostic Applications
6.2.4 Research Applications
6.2.5 Others
6.3 Global Nanotechnology in Medical Devices Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Long Term Care Centers
6.3.4 Households
6.3.5 Home Care Settings
6.3.6 Ambulatory Surgical Centers
6.3.7 Urgent Care Center
6.3.8 Others
6.4 Global Nanotechnology in Medical Devices Market by Distribution Channel
6.4.1 Market Overview
6.4.2 Wholesalers/Distributors
6.4.3 Online Retailers
6.4.4 Multi-brand Stores
6.4.5 Specialty Stores
6.4.6 Others
6.5 Global Nanotechnology in Medical Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Nanotechnology in Medical Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nanotechnology in Medical Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nanotechnology in Medical Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nanotechnology in Medical Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nanotechnology in Medical Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 3M
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Dentsply Sirona
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Thermo Fisher Scientific
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 PerkinElmer Inc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 General Electric Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Ferro Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Eppendorf AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Merck KGaA
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 ZELLMECHANIK DRESDEN
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 TÜV Rheinland
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Medtronic
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Boston Scientific Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 BIOTRONIK
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 LivaNova PLC
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Demant A/S
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Nanotechnology in Medical Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market reached a value of USD 7.55 billion in 2022.
The market is estimated to grow at a CAGR of 10.20% in the forecast period of 2023-2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach a value of USD 13.31 billion by 2028.
The increasing prevalence of chronic conditions such as cancer, osteoporosis, and tuberculosis, among others, rising healthcare expenditure across the emerging economies, and growing demand for implants and advanced therapeutical medications, are the major drivers of the market.
The key trends in the nanotechnology in medical devices market include technological advancements in nanomaterials, advanced 3D implantation, and increasing penetration of artificial intelligence and Internet of Things.
Active implantable devices, biochips, implantable materials, and medical textiles and wound dressings, among others, are the different products included in the market.
Therapeutic applications, diagnostic applications, and research applications are the segments of the market based on application.
Nanotechnology is growing in importance in healthcare due to its ability to reduce costs of medical diagnostics and enhancing convenience.
Embedding nanotechnology and nanoscale sensors into implants is an emerging potential application of nanotechnology in medicine which could enable the detection of infection at earlier stages.
Smith & Nephew plc, Stryker Corporation, Abbott Laboratories, PerkinElmer Inc., and Starkey Laboratories, Inc., among others, are the key market players, according to the report.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999$5999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER